Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors.

OBJECTIVE Beta-defensins are broad-spectrum antimicrobial peptides (APs) that are components of innate immunity. Recent investigations showed the induction of beta-defensins in synovial membranes of osteoarthritic (OA) joints and suggested that they have functions other than the ability to kill microbes. As a result of these findings, we undertook this study to investigate the production of human beta-defensin 3 (HBD-3) in OA cartilage and to determine its influence on chondrocyte function. METHODS Healthy and OA cartilage were assessed for HBD-3 expression by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. HBD-3 expression in C28/I2 chondrocytes after administration of tumor necrosis factor alpha (TNFalpha) and interleukin-1 (IL-1) was determined by real-time RT-PCR and immunodot blot. Enzyme-linked immunosorbent assay experiments were used to study the effects of HBD-3 in cultured articular chondrocytes and in healthy and OA cartilage discs. Immunohistochemical analyses were performed to study the expression of mouse beta-defensins (MBDs) in OA cartilage of STR/Ort mice. RESULTS HBD-3 was induced in OA cartilage without bacterial challenge. Cytokines involved in the pathogenesis of OA, namely, TNFalpha and IL-1, were strong inducers of HBD-3 in cultured chondrocytes. Application of the recombinant HBD-3 protein to cultured chondrocytes and cartilage discs resulted in increased production of cartilage-degrading matrix metalloproteinases and in down-regulation of their endogenous regulators, tissue inhibitors of metalloproteinases 1 and 2. Furthermore, STR/Ort mice, which are genetically predisposed to develop OA-like lesions in the knee joint, demonstrated an increased expression of MBDs 3 and 4 in cartilage compared with that in healthy animals. CONCLUSION These findings widen our knowledge of the functional spectrum of APs and demonstrate that HBD-3 is a multifunctional AP with the ability to link host defense mechanisms and inflammation with tissue-remodeling processes in articular cartilage. Moreover, our data suggest that HBD-3 is an additional factor in the pathogenesis of OA.

[1]  M. Walton.  Studies of degenerative joint disease in the mouse knee joint; scanning electron microscopy , 1977, The Journal of pathology.

[2]  T. Pufe,et al.  Production of endogenous antibiotics in articular cartilage. , 2004, Arthritis and rheumatism.

[3]  E. Greenberg,et al.  Production of β-defensins by human airway epithelia , 1998 .

[4]  B. Jost,et al.  Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice. , 2002, Osteoarthritis and cartilage.

[5]  J. Glowacki,et al.  Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. , 1994, The Journal of clinical investigation.

[6]  Marc Thibault,et al.  Cyclic compression of cartilage/bone explants in vitro leads to physical weakening, mechanical breakdown of collagen and release of matrix fragments , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  R. Bals,et al.  Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Mason,et al.  The STR/ort mouse and its use as a model of osteoarthritis. , 2001, Osteoarthritis and cartilage.

[9]  L. Schwichtenberg,et al.  Mucoid Pseudomonas aeruginosa, TNF- α , and IL-1 β , but Not IL-6, Induce Human β -Defensin-2 in Respiratory Epithelia , 2000 .

[10]  M. Kagnoff,et al.  Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.

[11]  S. Abramson,et al.  Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. , 2001, Arthritis and rheumatism.

[12]  R. Mason,et al.  Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. , 2002, Osteoarthritis and cartilage.

[13]  M. Goldring,et al.  The role of the chondrocyte in osteoarthritis. , 2000, Arthritis and rheumatism.

[14]  V. Bafna,et al.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.

[15]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[16]  S. Wattler,et al.  Mouse β-Defensin 3 Is an Inducible Antimicrobial Peptide Expressed in the Epithelia of Multiple Organs , 1999, Infection and Immunity.

[17]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[18]  T. Pufe,et al.  Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes , 2002, The Journal of pathology.

[19]  M. Goldring,et al.  Osteoarthritis and cartilage: The role of cytokines , 2000, Current rheumatology reports.

[20]  V. Harde,et al.  Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes , 2004, The Journal of pathology.

[21]  R. Mason,et al.  Chondrocyte cytokine and growth factor expression in murine osteoarthritis. , 1997, Osteoarthritis and cartilage.

[22]  Gillian Murphy,et al.  Metalloproteinase inhibitors: biological actions and therapeutic opportunities , 2002, Journal of Cell Science.

[23]  H. Dorfman,et al.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. , 1971, The Journal of bone and joint surgery. American volume.

[24]  B Kurz,et al.  Biosynthetic response and mechanical properties of articular cartilage after injurious compression , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  S. Randell,et al.  CD14-dependent Lipopolysaccharide-induced β-Defensin-2 Expression in Human Tracheobronchial Epithelium* , 2000, The Journal of Biological Chemistry.

[26]  Y. Ouchi,et al.  Identification of Multiple Novel Epididymis-Specific β-Defensin Isoforms in Humans and Mice1 , 2002, The Journal of Immunology.

[27]  T. Ganz,et al.  Wound Healing and Expression of Antimicrobial Peptides/Polypeptides in Human Keratinocytes, a Consequence of Common Growth Factors1 , 2003, The Journal of Immunology.

[28]  D. Hoover,et al.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Burd,et al.  Murine &Bgr;-Defensin-3 Is an Inducible Peptide with Limited Tissue Expression and Broad-Spectrum Antimicrobial Activity , 2002, Shock.

[30]  M. Raida,et al.  hBD‐1: a novel β‐defensin from human plasma , 1995 .

[31]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[32]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[33]  Christina H. Park,et al.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. , 1998, The Journal of clinical investigation.

[34]  K. Geoghegan,et al.  Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.

[35]  T. Ganz,et al.  By IL-1 Signaling, Monocyte-Derived Cells Dramatically Enhance the Epidermal Antimicrobial Response to Lipopolysaccharide1 , 2003, The Journal of Immunology.

[36]  M. Goldring.  Anticytokine therapy for osteoarthritis , 2001, Expert opinion on biological therapy.

[37]  Andrej Tarkowski,et al.  Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis , 1999, Nature Medicine.

[38]  K. King-Jones,et al.  Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1. , 2003, Arthritis and rheumatism.

[39]  T. Pufe,et al.  Expression of Natural Peptide Antibiotics in Human Articular Cartilage and Synovial Membrane , 2001, Clinical Diagnostic Laboratory Immunology.

[40]  C. Brinckerhoff,et al.  Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.

[41]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[42]  S. Chubinskaya,et al.  Modulation of Endogenous Osteogenic Protein-1 (OP-1) by Interleukin-1 in Adult Human Articular Cartilage , 2003, The Journal of bone and joint surgery. American volume.

[43]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[44]  D. Davidson,et al.  A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide , 1999, FEBS letters.

[45]  R. Mason,et al.  Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. , 2001, Arthritis and rheumatism.

[46]  Linda J. Sandell,et al.  Egr-1 Mediates Transcriptional Repression of COL2A1Promoter Activity by Interleukin-1β* , 2003, The Journal of Biological Chemistry.

[47]  T. Libermann,et al.  Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. , 2003, Arthritis and rheumatism.